Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Freedonia Group
Freedonia Group
Activities:
Media
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Media
World enzyme demand to reach $7.2bn
Food and beverages will remain the largest market for enzymes
Media
US aseptic packaging demand to reach US$6.4bn in 2020
Growth will be driven by advances in processing, as well as the ability of products in aseptic packaging to be distributed and stored at ambient temperatures
Media
US demand for drug delivery products to reach US$251bn
Demand for drug delivery products in the US is projected to increase 6.1% annually to reach US$251bn in 2019
Media
US enzyme demand to reach US$2.2bn in 2019
In more mature industrial markets, efforts to reduce energy and water use will continue to have a positive impact on enzyme demand
Media
Pharma packaging demand to reach US$18.5bn by 2014
Prefillable syringes expected to show highest growth in primary pharmaceutical containers in US
Ingredients
Global demand for enzymes to approach $6bn in 2011
The world market for enzymes will grow 7.6% per year to US$6bn in 2011</p>
Packaging
World demand for pharmaceutical packaging will continue to rise
To increase at an annual rate of 4.3% to reach US$22.2bn in 2007
Subscribe now